TCT-242 Prospective Validation of the ARC-HBR, PRECISE-DAPT, and PARIS Risk Prediction Model in the All-Comer PIONEER IV Trial

TsungYing Tsai; Joanna J. Wykrzykowska; Faisal Sharif; Liesbeth Rosseel; Julie Colas-Florial; Mohammad Alkhalil; Edouard Benit; Nick Curzen; Vincent Floré; Kenneth De Wilder; Valeria Paradies; Giovanni Amoroso; Sjoerd H. Hofma; Samer Somi; Adel Aminian; Clemens von Birgelen; Manel Sabaté; Víctor Alfonso Jiménez Díaz; Ignacio J. Amat‐Santos; Jeroen Sonck; Anthony Mathur; Lionel Mangin; Mathieu Pankert; Gilles Barone-Rochette; Raymundo Ocaranza‐Sánchez; Julien Adjedj; Kotaro Miyashita; Akihiro Tobe; Asahi Oshima; David van Klaveren; Yoshinobu Onuma; Patrick W. Serruys

doi:10.1016/j.jacc.2024.09.283

Related publications

Article2018

TCT-835 Validation of PARIS Risk Scores in Patients Treated With Everolimus-Eluting Stents for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

Sabato Sorrentino, Bimmer E. Claessen, Roxana Mehran, David E. Kandzari, Marie‐Claude Morice, Martin B. Leon, Bernard J. Gersh, Ori Ben‐Yehuda, Björn Redfors, Ovidiu Dressler, Stuart Pocock, A. Pieter Kappetein, Joseph F. Sabik, Patrick W. Serruys, Gregg W. Stone

Journal of the American College of Cardiology

Article2019

PREDICTIVE ABILITY OF THE PARIS RISK SCORE IN ALL-COMERS PATIENTS UNDERGOING PCI WITH DRUG ELUTING STENTS: EXTERNAL VALIDATION IN THE GLOBAL LEADERS STUDY

Ply Chichareon, Usman Baber, Rodrigo Modolo, Chun‐Chin Chang, Norihiro Kogame, Kuniaki Takahashi, Mariusz Tomaniak, Yuki Katagiri, Salvatore Curello, Gavin Galasko, Gregor Leibundgut, Victor A. Umans, Guy Friedrich, Tim Seidler, Ernest Spitzer, Yoshinobu Onuma, Philippe Steg, Christian Hamm, Peter Jüni, Pascal Vranckx, Marco Valgimigli, Stephan Windecker, David van Klaveren,

Article2018

TCT-676 Could the logistic clinical SYNTAX score have predicted the all-cause mortality in the Global Leaders trial? A prediction prior to the unblinding of the trial

Ply Chichareon, Rodrigo Modolo, Norihiro Kogame, Kuniaki Takahashi, Taku Asano, Yuki Katagiri, Chun‐Chin Chang, Carlos Collet, Franz‐Josef Neumann, Keith G. Oldroyd, Richard Anderson, Farzin Fath‐Ordoubadi, Christoph Naber, Scot Garg, Ivo Petrov, Pascal Vranckx, Marco Valgimigli, Stephan Windecker, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Letter2024

Temporal trend and regional disparity in the investigations for stable chest pain in Europe: An insight from the PIONEER IV trial

Tsung‐Ying Tsai, Patrick W. Serruys, Joanna J. Wykrzykowska, Faisal Sharif, Liesbeth Rosseel, Edouard Benit, Mohammad Alkhalil, Kenneth De Wilder, Nick Curzen, Mick Renkens, Pruthvi C. Revaiah, Andreas Baumbach, Pieter C. Smits, P Nash, Scot Garg, Marc Dewey, Thomas F. Lüscher, Yoshinobu Onuma

Journal of cardiovascular computed tomography

Article2019

TCT-420 Derivation and External Validation of a Novel Risk Score for Prediction of 30-Day Mortality After Percutaneous Coronary Intervention

Sorin J. Brener, Martin B. Leon, Patrick W. Serruys, Pieter C. Smits, Clemens von Birgelen, Roxana Mehran, Ori Ben‐Yehuda, Ajay J. Kirtane, Bernhard Witzenbichler, Giora Weisz, Michael J. Rinaldi, D. Christopher Metzger, Timothy D. Henry, David A. Cox, Peter L. Duffy, Ernest L. Mazzaferri, Zixuan Zhang, Thomas McAndrew, Gregg W. Stone

Journal of the American College of Cardiology

TCT-242 Prospective Validation of the ARC-HBR, PRECISE-DAPT, and PARIS Risk Prediction Model in the All-Comer PIONEER IV Trial

Abstract

Discussion(0)

Related publications

TCT-835 Validation of PARIS Risk Scores in Patients Treated With Everolimus-Eluting Stents for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

PREDICTIVE ABILITY OF THE PARIS RISK SCORE IN ALL-COMERS PATIENTS UNDERGOING PCI WITH DRUG ELUTING STENTS: EXTERNAL VALIDATION IN THE GLOBAL LEADERS STUDY

TCT-676 Could the logistic clinical SYNTAX score have predicted the all-cause mortality in the Global Leaders trial? A prediction prior to the unblinding of the trial

Temporal trend and regional disparity in the investigations for stable chest pain in Europe: An insight from the PIONEER IV trial

TCT-420 Derivation and External Validation of a Novel Risk Score for Prediction of 30-Day Mortality After Percutaneous Coronary Intervention